Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 6, 2010, Pages 1416-1419

  Biss, T T ^a   Blanchette, V S ^a,b   Clark, D S ^a   Wakefield, C D ^a   James, P D ^c   Rand, M L ^a,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD; CLINICAL ARTICLE; CONJUNCTIVAL HEMORRHAGE; DENSE GRANULE DEFICIENCY; DISEASE SEVERITY; EHLERS DANLOS SYNDROME; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLANZMANN DISEASE; HEMARTHROSIS; HEMATURIA; HUMAN; INFANT; LETTER; MALE; MUCOSAL BLEEDING; MUSCLE HEMATOMA; NOONAN SYNDROME; OCULAR ALBINISM; ORAL BLEEDING; PEDIATRIC BLEEDING QUESTIONNAIRE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SKIN BLEEDING; SKIN BRUISING; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

ADOLESCENT; BLOOD PLATELET DISORDERS; CHILD; FEMALE; HEMORRHAGE; HUMANS; MALE; MUCOUS MEMBRANE; PEDIATRICS; QUESTIONNAIRES; SKIN;

EID: 77954506430     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03846.x     Document Type: Letter

References (15)

1. Buchanan GR. Bleeding signs in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003, 25(Suppl. 1):S42-6.
2. Page LK, Psaila B, Provan D, Hamilton JM, Jenkins JM, Elish AS, Lesser ML, Bussel JB. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 2007, 138:245-8.
3. McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, Heddle NM, Rivard GE, Hayward CPM. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004, 104:159-65.
4. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009, 7:1418-21.
5. Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappellitti A, Casana P, De Bosch N, Eikenboom JCJ, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005, 3:2619-26.
6. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost 2006, 4:766-73.
7. Nurden AT, George JN. Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders. Hemostasis and Thrombosis 2006, 987-1010. Colman RW, Marder VJClowes AWGeorge JNGoldhaber SZ. eds, 5th edn, Philadelphia, Lippincott, Williams & Wilkins
8. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine 2003, 82:203-15.
9. Wright JF, Wang H, Hornstein A, Hogarth M, Mody M, Garvey MB, Blanchette V, Rock G, Freedman J. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1999, 107:546-55.
10. Mody M, Lazarus AH, Semple JW, Freedman J. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfus Med 1999, 9:147-54.
11. White JG. The dense bodies of human platelets: inherent electron opacity of the serotonin storage particles. Blood 1969, 33:598-606.
12. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo EK, Inoue C, Kamiya T, Saito H. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 2003, 83:115-22.
13. Biss TT, Blanchette VS, Clark DS, Bowman M, Wakefield CD, Silva M, Lillicrap D, James PD, Rand ML. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010, 8:950-6.
14. Witt DR, McGillivray BC, Allanson JE, Hughes HE, Hathaway WE, Zipursky A, Hall JG. Bleeding diathesis in Noonan syndrome: a common association. Am J Med Genet 1988, 31:305-17.
15. De Paepe A, Malfait F. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 2004, 127:491-500.